HERTFORDSHIRE, England, and PITTSBURGH, June 8, 2015 /PRNewswire/ — Mylan N.V. (Nasdaq: MYL) today announced that it has launched the first bioequivalent alternative to GlaxoSmithKline’s Seretide® Evohaler® (salmeterol xinafoate/fluticasone propionate) under […]
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced the launch of the generic equivalent to INTUNIV® (guanfacine) 1 mg, 2 mg, 3 mg, and 4 mg, in the United States. […]
CHESTNUT RIDGE, N.Y., May 26, 2015 /PRNewswire/ — Par Specialty Pharmaceuticals, a division of Par Pharmaceutical, Inc., today announced the launch of Cortisporin®-TC Otic Suspension (colistin sulfate – neomycin sulfate – […]
CINCINNATI–(BUSINESS WIRE)–Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has received the CE Mark for new molecular assays for the detection of Herpes Simplex Virus Type 1 (HSV-1) and […]
BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. today announced the launch of GeneStrat™, a targeted liquid biopsy mutation test for genotyping tumors of patients with advanced non-small cell lung cancer (NSCLC). The blood […]
MADISON, N.J.–(BUSINESS WIRE)–Pfizer Consumer Healthcare, the makers of America’s most-preferred and most-clinically studied multivitamin brand, Centrum®, has announced the launch of Centrum® MultiGummies, a great-tasting, easy-to-take multivitamin, specifically designed with […]